AFJK Aimei Health Technology Co., Ltd

NAS · US · Financial Services · Shell Companies

12.12USD-1.86%Mkt Cap: 38.38M $P/E: 173.141d ago

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition stock purchase, reorganization, or similar business combination with one or more bus…

Industry Peers

Shell Companies

Armada Acquisition Corp. II

$790.07MUSDP/E 227.4

DMII

Drugs Made In America Acquisition II Corp.

$649.10MUSDP/E 34.0

CCXI

Churchill Capital Corp XI

$626.07MUSD

EVAC

EQV Ventures Acquisition Corp. II

$602.60MUSDP/E 34.4

BCSS

Bain Capital GSS Investment Cor

$596.85MUSD

CXII

Churchill Capital Corp XII

$591.61MUSD

CEPF

Cantor Equity Partners IV, Inc.

$586.93MUSDP/E 31.1

AC8

Intuitive Investments Group Plc

$532.06MUSDP/E 2.5

AEXA

American Exceptionalism Acquisition Corp. A

$536.65MUSD

NWAX

New America Acquisition I Corp.

$500.24MUSD

AAC

Ares Acquisition Corporation III

$496.66MUSD

MLAA

Mountain Lake Acquisition Corp. II

$490.34MUSD

KRSP

Rice Acquisition Corporation 3

$486.71MUSD

BRTM

B&R Technology Merger Corp.

$478.69MUSD

CRAN

Crane Harbor Acquisition Corp. II

$473.69MUSD

GTEN

Gores Holdings X, Inc.

$470.58MUSDP/E 21.3

GCGR

General Catalyst Global Resilience Merger Corp.

$467.87MUSD

APXT

Apex Treasury Corporation

$466.49MUSD

BCCQ

Bleichroeder Acquisition Corp. III

$457.24MUSD

Key Statistics

Company

Market Cap38.38M USD

Enterprise Value42.43M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)1.06M USD

Revenue/Share—

Last Price12.12 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees—

CountryUS

SectorFinancial Services

IndustryShell Companies

ISIN—

Valuation

P/E (Trailing)173.14

P/E (Forward)—

PEG—

EV/EBITDA—

EV/Revenue—

P/S—

P/B-8.72

EPS (TTM)0.07

EPS (Forward)—

52W Range

6.7504% of range130.37

52W High130.37 USD

52W Low6.750 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE13.18%

ROA8.76%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-565.10K USD

CapEx (TTM)—

FCF Margin—

FCF Yield-2.32%

Net Debt3.32M USD

Net Debt/EBITDA—

Balance Sheet

Debt/Equity0.25

Current Ratio0.01

Quick Ratio0.00

Book Value/Sh-1.42 USD

Cash/Share0.00 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.3.17M

Float1.11M

Insiders64.96%

Institutions32.02%

Short Interest

Short Ratio0.1d

Short % Float0.19%

Short % Out.0.07%

Shares Short2.11K

Short (prev mo.)2.29K

Technical

SMA 5012.14 (-0.2%)

SMA 20032.31 (-62.5%)

Beta0.91

S&P 52W Chg16.45%

Avg Vol (30d)22.57K

Avg Vol (10d)2.45K

Technical Indicators

RSI (14)42.9

MACD-0.2822

MACD Signal-0.4227

MACD Hist.+0.1405

BB Upper12.55 USD

BB Middle12.21 USD

BB Lower11.87 USD

BB Width5.54%

ATR (14)0.4006 USD

Vol Ratio (20d)0.06x